In:
Current Pharmaceutical Design, Bentham Science Publishers Ltd., Vol. 28, No. 2 ( 2022-01), p. 133-150
Abstract:
Early detection and accurate monitoring are two critical factors affecting the outcome of anticancer
therapy. However, both these factors are affected by the limitations of conventional approaches of diagnosis and treatment. Nanomedicine has progressively offered a scientific solution in improved delivery and better diagnosis
of various cancers, thus providing a targeted treatment approach. With the advances in the field, simultaneous delivery and diagnosis are becoming a reality. The present manuscript discusses various drug delivery
challenges, provides the scope for theranostic nanomaterials in the diagnosis and treatment of cancer. The clinical and translational potential of theranostic nanomedicine and the future directions for further research are also
presented in the manuscript.
Type of Medium:
Online Resource
ISSN:
1381-6128
DOI:
10.2174/1381612827666210916140627
Language:
English
Publisher:
Bentham Science Publishers Ltd.
Publication Date:
2022
SSG:
15,3
Bookmarklink